B

Bioton SA
WSE:BIO

Watchlist Manager
Bioton SA
WSE:BIO
Watchlist
Price: 3.96 PLN 0.76% Market Closed
Market Cap: 340m PLN

DCF Value

This DCF valuation model was created by Alpha Spread and was last updated on Nov 29, 2025.

Estimated DCF Value of one BIO stock is 3.05 PLN. Compared to the current market price of 3.96 PLN, the stock is Overvalued by 23%.

BIO DCF Value
Base Case
3.05 PLN
Overvaluation 23%
DCF Value
Price
B
Worst Case
Base Case
Best Case
DCF Value: 3.05 PLN

Present Value Calculation

This block is the starting point of the DCF valuation process. It calculates the present value of a company's forecasted cash flows based on selected operating model. Adjust key parameters like discount rate and terminal growth, and alter inputs such as revenue growth and margins to see their impact on valuation.

DCF Model
Base Case Scenario

The present value of cash flows over the next 5 years amounts to 105.2m PLN. The present value of the terminal value is 169.5m PLN. The total present value equals 274.6m PLN.
Forecast Period
Years
Discount Rate
%
Terminal Growth
%
Hide DCF Settings
Rotate your device to view
DCF Model
Year 1

forecasted

Year 2

forecasted

Year 3

forecasted

Year 4

forecasted

Year 5

forecasted

Terminal

forecasted

Operating Income
Revenue256299338372397410
Absolute Value
Growth
Operating Margin7.05%7.05%7.47%7.59%7.71%7.84%
Absolute Value
Operating Income182125283132
Net Operating Profit After Taxes
Taxes-3-4-5-6-6-6
Absolute Value
As % of Operating Income
NOPAT151720232526
Free Cash Flow to Firm
Net CapEx9101010109
Absolute Value
As % of Revenue
FCFF242730333435
Present Value
Discount Rate11.75%11.75%11.75%11.75%11.75%11.75%
Present Value2121222120169
Save

DCF Value Calculation

This stage translates the present value into DCF value per share. For firm valuation models, it adjusts present value for debt and assets to derive equity value (skipped if using equity valuation model). Finally, this equity value is divided by the number of shares to determine the DCF value per share.

Present Value to DCF Value
Capital Structure

Present Value 274.6m PLN
+ Cash & Equivalents 1.4m PLN
Firm Value 276.1m PLN
- Debt 14m PLN
Equity Value 262.1m PLN
/ Shares Outstanding 85.9m
BIO DCF Value 3.05 PLN
Overvalued by 23%

Valuation Analysis

Sensitivity Analysis
DCF Value Sensitivity Analysis

Sensitivity Analysis assesses how changes in key factors like revenue growth, margin, and discount rate affect a stock's DCF value. By visualizing various scenarios, from significant downturns to optimistic growth, this tool helps you understand potential valuation shifts, aiding in risk assessment and strategic decision-making.

DCF Financials
Financials used in DCF Calculation

Revenue
255.8m 410.5m
Operating Income
18m 32.2m
FCFF
23.6m 34.7m

What is the DCF value of one BIO stock?

Estimated DCF Value of one BIO stock is 3.05 PLN. Compared to the current market price of 3.96 PLN, the stock is Overvalued by 23%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Utilizing the DCF operating model, Bioton SA's future cash flows are projected and then discounted using a chosen discount rate to determine its Present Value, which is calculated at 274.6m PLN.

2. DCF Value Calculation. The company's capital structure is employed to derive the total Equity Value from the previously calculated Present Value of the cash flow. This Equity Value, when divided by the total number of outstanding shares, yields the DCF Value of 3.05 PLN per share.

Back to Top